143 related articles for article (PubMed ID: 3855968)
1. Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation.
Livrea P; Trojano M; Simone IL; Zimatore GB; Logroscino GC; Pisicchio L; Lojacono G; Colella R; Ceci A
J Neurol; 1985; 231(6):336-9. PubMed ID: 3855968
[TBL] [Abstract][Full Text] [Related]
2. [Changes in the blood-cerebrospinal fluid barrier for serum proteins in children with acute lymphatic leukemia].
Ludwig R; Kretzmann R; Burger R; Brandeis WE
Klin Wochenschr; 1987 Jan; 65(2):76-81. PubMed ID: 2435954
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients.
Livrea P; Trojano M; Simone IL; Zimatore GB; Pisicchio L; Logroscino G; Cibelli G
J Neurol Sci; 1984 Jun; 64(3):245-58. PubMed ID: 6206205
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).
Littman P; Coccia P; Bleyer WA; Lukens J; Siegel S; Miller D; Sather H; Hammond D
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1443-9. PubMed ID: 3305443
[TBL] [Abstract][Full Text] [Related]
5. Changes of CSF-protein pattern in children with acute lymphoblastic leukemia during prophylactic CNS therapy (Berlin protocol).
Siemes H; Rating D; Siegert M; Hanefeld F; Müller S; Gadner H; Riehm H
Med Pediatr Oncol; 1980; 8(1):25-34. PubMed ID: 6934368
[TBL] [Abstract][Full Text] [Related]
6. The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemia.
Dritschilo A; Cassady JR; Camitta B; Jaffe N; Furman L; Traggis D
Cancer; 1976 Jun; 37(6):2729-35. PubMed ID: 1065467
[TBL] [Abstract][Full Text] [Related]
7. Studies on the assessment of neurotoxicity in children with acute lymphoblastic leukemia.
Muchi H; Satoh T; Yamamoto K; Karube T; Miyao M
Cancer; 1987 Mar; 59(5):891-5. PubMed ID: 3469009
[TBL] [Abstract][Full Text] [Related]
8. [Effect of cranial irradiation on the blood-cerebrospinal fluid and blood-brain barrier].
Ludwig R
Klin Padiatr; 1987; 199(3):233-8. PubMed ID: 3476804
[TBL] [Abstract][Full Text] [Related]
9. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen.
Bleyer WA; Coccia PF; Sather HN; Level C; Lukens J; Niebrugge DJ; Siegel S; Littman PS; Leikin SL; Miller DR
J Clin Oncol; 1983 May; 1(5):317-25. PubMed ID: 6366138
[TBL] [Abstract][Full Text] [Related]
10. Computerized tomography scan findings in children with acute lymphocytic leukemia treated with three different methods of central nervous system prophylaxis.
Brecher ML; Berger P; Freeman AI; Krischer J; Boyett J; Glicksman AS; Foreman E; Harris M; Jones B; Cohen ME
Cancer; 1985 Nov; 56(10):2430-3. PubMed ID: 3862463
[TBL] [Abstract][Full Text] [Related]
11. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
Pinkerton CR; Chessells JM
Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
[TBL] [Abstract][Full Text] [Related]
12. Analysis of treatment in childhood leukaemia. I. Predisposition to methotrexate-induced neutropenia after craniospinal irradiation. Report to the Medical Research Council of the Working Party on Leukaemia in Childhood.
Br Med J; 1975 Sep; 3(5983):563-6. PubMed ID: 1100179
[TBL] [Abstract][Full Text] [Related]
13. CNS prophylaxis using a triple intrathecal drug therapy without cranial irradiation in acute lymphoblastic leukaemia.
Asfour I; Misset JL; Mathe G; Sabbour MS
Int J Clin Pharmacol Res; 1988; 8(1):47-54. PubMed ID: 3163327
[TBL] [Abstract][Full Text] [Related]
14. Intermittent central nervous system irradiation and intrathecal chemotherapy for central nervous system leukemia in children.
Kim TH; Ramsay NK; Steeves RA; Nesbit ME
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1451-5. PubMed ID: 3624023
[TBL] [Abstract][Full Text] [Related]
15. The effect of cranial irradiation on blood-brain barrier permeability to methotrexate.
Seshadri RS; Ryall RG; Rice MS; Leahy M; Ellis R
Aust Paediatr J; 1979 Sep; 15(3):184-5. PubMed ID: 293161
[No Abstract] [Full Text] [Related]
16. Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group.
Nesbit ME; Sather HN; Robison LL; Ortega J; Littman PS; D'Angio GJ; Hammond GD
Lancet; 1981 Feb; 1(8218):461-6. PubMed ID: 6110090
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic central nervous system therapy with cranial irradiation and intrathecal methotrexate in acute lymphoblastic leukemia of childhood.
Wehinger H; Slanina J; Jacobi H; Musshoff K; Dietz V; Sauer M; Dilger M
Strahlentherapie; 1974 Dec; 148(6):590-8. PubMed ID: 4532340
[No Abstract] [Full Text] [Related]
18. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
Ribeiro RC; Rivera GK; Hudson M; Mulhern RK; Hancock ML; Kun L; Mahmoud H; Sandlund JT; Crist WM; Pui CH
J Clin Oncol; 1995 Feb; 13(2):333-8. PubMed ID: 7844594
[TBL] [Abstract][Full Text] [Related]
19. Effects of central-nervous-system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia.
Soni SS; Marten GW; Pitner SE; Duenas DA; Powazek M
N Engl J Med; 1975 Jul; 293(3):113-8. PubMed ID: 1055858
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia.
Raje NS; Vaidya SJ; Kapoor G; Pai SK; Nair CN; Kurkure PA; Magrath IT; Advani SH
Indian Pediatr; 1996 Jul; 33(7):556-60. PubMed ID: 8979564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
